CROs offering Target Identification & Validation with Small Molecule
23 published
23 published CROs match Target Identification & Validation and Small Molecule.
Locations in this set include United States, China, India, United Kingdom, France, and Canada.
Capabilities that show up most often in this set: Discovery Research, Medicinal Chemistry, Computational & In-Silico Drug Discovery, High-Throughput Screening, and In Vitro ADME / DMPK.
Matching companies
Sygnature DiscoveryIntegrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /explore/target-identification-validation/small-molecule.md